Responding to international outcry after a Chinese scientist claimed to have helped create gene-edited babies, China has drafted a series of new regulations on gene editing.
The proposed new National Health Commission rules on clinical research address gene editing, gene transfer, and gene regulation. All would be designated as high-risk and would be subject to oversight by China's national cabinet, the State Council. The rules have not yet been adopted.
About Pacific Bridge Medical
Pacific Bridge Medical (PBM) was founded in 1988 to help international medical companies solve their most complex problems while doing business in Asia. Since then, PBM has assisted hundreds of healthcare companies with regulatory issues in Asia. We provide our services to all types of medical firms, including medical device, IVD, pharmaceutical, and API.
------------------------------
Ames Gross
President
Pacific Bridge Medical
Bethesda, MD
www.pacificbridgemedical.comcontact@pacificbridgemedical.com------------------------------